Nanovectors including GNVs (#1), lymphocyte membrane-coated GNVs, IGNVs (#2), DOTAP:DOPE liposomes (#3) and liposomes from Avanti (#4) were labeled with DiR dye and I.V. injected into normal mice. (A) Live body images were collected at different time points (30 min, 60 min, 6 h and 12 h). (B) Mice were sacrificed, organs including liver, spleen, lung, kidney, heart, thymus, brain and stomach were removed and the DiR signals in organs were quantified by scanning using a Kodak Images Station. Representative images of DiR labeled nanovectors from mice (A), and organs (B). (C) Cell targets of PKH26 labeled particles in liver. Nanovectors were labeled with PKH26 and I.V. injected into mice, livers from mice were removed and tissue sections were stained with antimouse F4/80 antibody. The data (A-C) shown is a representative of at least 2 independent experiments (n=5).
Supplementary Figure 4.
Average body weight of male C57BL/6 mice. Six-week-old B6 mice (n = 5) were I.V. injected with autologous blood derived exosomes (200 g in 100 L PBS) or PBS as a control. Body weight was measured over the period of 3 weeks and expressed as % of gained body weight over 3 weeks period. NS: not significant; p>0.05.
Supplementary Figure 5.
Loading efficiency of doxorubicin and paclitaxel on GNVs. GNV-Dox and GNV-PTX were prepared by bath-sonication, the residual Dox (A) or PTX (B) in the supernatant was quantitatively analyzed by UV-Visible spectrophotometer at a wavelength of 486 and 265 nm, respectively and the loading efficiency was calculated and expressed as (Total drug-amount of drug in the supernatant)/Total drug×100% (C).
